Chromatin and transcriptomic profiling uncover dysregulation of the Tip60 HAT/HDAC2 epigenomic landscape in the neurodegenerative brain
Mariah BeaveriD, Bhanu Chandra KarisettyiD, Haolin ZhangiD, Akanksha BhatnagariD, Ellen M. ArmouriD, Visha ParmariD, Reshma Brown, Merry Xiang, Felice ElefantiD
Abstract
Disruption of histone acetylation mediated gene control is a critical step in Alzheimers Disease (AD), yet chromatin analysis of antagonistic histone acetyltransferases (HATs) and histone deacetylases (HDACs) causing these alterations remains uncharacterized. We report the first Tip60 HAT versus HDAC2 chromatin and transcriptional profiling study in Drosophila brains that model early human AD. We find Tip60 and HDAC2 predominantly recruited to identical neuronal genes. Moreover, AD brains exhibit robust genome-wide early alterations that include enhanced HDAC2 and reduced Tip60 binding and transcriptional dysregulation. Orthologous human genes to co-Tip60/HDAC2 Drosophila neural targets exhibit conserved disruption patterns in AD patient hippocampi. Notably, we discovered distinct transcription factor (TF) binding sites within Tip60/HDAC2 co-peaks in neuronal genes, implicating them in co-enzyme recruitment. Increased Tip60 protects against transcriptional dysregulation and enhanced HDAC2 enrichment genome-wide. We advocate Tip60 HAT/HDAC2 mediated epigenetic neuronal gene disruption as a genome-wide initial causal event in AD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 16
- FWCI
- 0.63
- Field percentile
- top 38%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tip60 protects against amyloid-β peptide-induced transcriptomic alterations via different modes of action in early versus late stages of neurodegenerative progression
Haolin Zhang, Bhanu Chandra Karisetty, … Felice Elefant·Molecular and Cellular NeurosciencePeer-reviewed·Nov 5, 2020
- The chromatin conformation landscape of Alzheimer's disease
Raffaella Nativio, Y Lan, … Shelley L. Berger·bioRxiv·Apr 9, 2024
- Histone acetylation in an Alzheimer's disease cell model promotes homeostatic amyloid-reducing pathways
Daniel C. Xu, Hanna Sas‐Nowosielska, … Shelley L. Berger·bioRxiv·Sep 18, 2023
- Neuronal HDAC9: A key regulator of cognitive and synaptic aging, rescuing Alzheimer's disease-related phenotypes
Yun Lei, Yuting Chen, … Xin‐Yun Lu·Molecular PsychiatryPeer-reviewed·Apr 4, 2026
- A histone acetylome-wide association study of Alzheimer’s disease: neuropathology-associated regulatory variation in the human entorhinal cortex
Sarah J. Marzi, Szi Kay Leung, … Jonathan S. Mill·Nature NeurosciencePeer-reviewed·Oct 11, 2018
- Cell type-specific histone acetylation profiling of Alzheimer's Disease subjects and integration with genetics
Easwaran Ramamurthy, Gwyneth Welch, … Andreas R. Pfenning·Frontiers in Molecular NeurosciencePeer-reviewed·Jan 6, 2023